Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-26 @ 1:18 AM
Study NCT ID:
NCT05265234
Status:
UNKNOWN
Last Update Posted:
2022-03-03
First Post:
2021-12-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
Sponsor:
OptiSkin Medical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-16
First Submit QC Date:
None
Study First Post Date:
2022-03-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-22
Last Update Post Date:
2022-03-03
Last Update Post Date Type:
ACTUAL